PT82392A - Hepatitis b surface antigen formed by recombinant dna techniques vaccines diagnostics cell lines and methods of forming same - Google Patents
Hepatitis b surface antigen formed by recombinant dna techniques vaccines diagnostics cell lines and methods of forming sameInfo
- Publication number
- PT82392A PT82392A PT82392A PT8239286A PT82392A PT 82392 A PT82392 A PT 82392A PT 82392 A PT82392 A PT 82392A PT 8239286 A PT8239286 A PT 8239286A PT 82392 A PT82392 A PT 82392A
- Authority
- PT
- Portugal
- Prior art keywords
- vaccines
- hepatitis
- methods
- cell lines
- recombinant dna
- Prior art date
Links
- 108020004511 Recombinant DNA Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
- G01N33/5764—Hepatitis B surface antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP85104521 | 1985-04-15 | ||
US85056786A | 1986-04-11 | 1986-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT82392A true PT82392A (en) | 1986-05-01 |
PT82392B PT82392B (en) | 1988-03-03 |
Family
ID=26096680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT82392A PT82392B (en) | 1985-04-15 | 1986-04-15 | Process for the preparation of a particle, a vaccine against hepatitis B and a protein and a diagnostic process |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR960004264B1 (en) |
AU (1) | AU606574B2 (en) |
DK (1) | DK171386A (en) |
FI (1) | FI95045C (en) |
HU (1) | HUT40699A (en) |
NO (1) | NO861450L (en) |
NZ (1) | NZ215820A (en) |
OA (1) | OA08238A (en) |
PT (1) | PT82392B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619753B2 (en) * | 1987-06-22 | 1992-02-06 | Medeva Holdings B.V. | Hepatitis b surface antigen vaccine |
-
1986
- 1986-04-14 NO NO861450A patent/NO861450L/en unknown
- 1986-04-14 FI FI861559A patent/FI95045C/en not_active IP Right Cessation
- 1986-04-14 NZ NZ215820A patent/NZ215820A/en unknown
- 1986-04-15 OA OA58835A patent/OA08238A/en unknown
- 1986-04-15 DK DK171386A patent/DK171386A/en not_active Application Discontinuation
- 1986-04-15 KR KR1019860002859A patent/KR960004264B1/en not_active IP Right Cessation
- 1986-04-15 HU HU861577A patent/HUT40699A/en unknown
- 1986-04-15 AU AU56114/86A patent/AU606574B2/en not_active Ceased
- 1986-04-15 PT PT82392A patent/PT82392B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5611486A (en) | 1986-10-23 |
KR860008284A (en) | 1986-11-14 |
NZ215820A (en) | 1989-01-06 |
OA08238A (en) | 1987-10-30 |
DK171386D0 (en) | 1986-04-15 |
HUT40699A (en) | 1987-01-28 |
KR960004264B1 (en) | 1996-03-30 |
FI861559A (en) | 1986-10-16 |
DK171386A (en) | 1986-10-16 |
FI861559A0 (en) | 1986-04-14 |
FI95045B (en) | 1995-08-31 |
AU606574B2 (en) | 1991-02-14 |
PT82392B (en) | 1988-03-03 |
NO861450L (en) | 1986-10-16 |
FI95045C (en) | 1995-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1003794A1 (en) | Hepatitis b surface antigen formed by recombinant dna techniques vaccines diagnostic cell lines and methods of forming same | |
IL85216A0 (en) | Hepatitis b virus surface antigens and hybrid antigens containing them | |
PH25249A (en) | Method for producing hepatitis b virus proteins in yeast | |
IL69423A0 (en) | Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen | |
GB8712936D0 (en) | Induction of gene expression in yeast | |
EP0105149A3 (en) | Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen | |
DE3474775D1 (en) | Method for purification of hepatitis b virus surface antigen | |
ZA868798B (en) | Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same | |
DE3378959D1 (en) | Methods for preparation of hepatitis b surface antigen free gamma globulins and products | |
PT85137A (en) | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen | |
EP0232410A4 (en) | Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells. | |
ZA861767B (en) | Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic | |
IL72452A0 (en) | Method for the preparation of yeast chromatin and its use for obtaining antibodies for the detection of mammalian carcinomas | |
JPS54141790A (en) | Modified dna and method of manufacturing hybrid protein using it | |
OA08238A (en) | Hepatitis B surface antigen formed by recombinant DNA techniques vaccines diagnostics cell lines and methods of forming same | |
DE3162469D1 (en) | Method of growing hepatitis b surface antigen | |
GB2181434A (en) | Hepatitis b virus vaccine and process for its preparation | |
ZA868612B (en) | Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells | |
IL83670A0 (en) | Dna coding for antigen protein of rinderpest virus and process for the preparation thereof | |
GR862721B (en) | Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells | |
IE871644L (en) | T and b cell epitopes of the pre-s region of hepatitis b¹virus surface antigen | |
SG139793G (en) | Preparation of hepatitis B surface antigen in yeast. | |
ZA869516B (en) | Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom | |
IE852110L (en) | Recombinant hepatitis antigen | |
ZA874498B (en) | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19920310 |
|
NF3A | Restitutio in integrum |
Effective date: 19920807 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20000331 |